CBIO - Catalyst Biosciences, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 8.87M
Enterprise value -12.75M
Trailing P/E 1.12
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.47
Price/book (mrq)0.26
Enterprise value/revenue -17.10
Enterprise value/EBITDA 0.63

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3-80.34%
S&P500 52-week change 33.90%
52-week high 32.0900
52-week low 30.1900
50-day moving average 30.2192
200-day moving average 30.5638

Share statistics

Avg vol (3-month) 3275.47k
Avg vol (10-day) 3196.21k
Shares outstanding 537.76M
Implied shares outstanding 6N/A
Float 827.23M
% held by insiders 128.19%
% held by institutions 113.66%
Shares short (14 May 2023) 4322.35k
Short ratio (14 May 2023) 41.68
Short % of float (14 May 2023) 40.86%
Short % of shares outstanding (14 May 2023) 40.85%
Shares short (prior month 13 Apr 2023) 4252.11k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 Jan 2023
Ex-dividend date 412 Jan 2023
Last split factor 21:15
Last split date 312 Feb 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-42.89%
Return on equity (ttm)38.06%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -20.13M
Net income avi to common (ttm)6.55M
Diluted EPS (ttm)0.2000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.1M
Total cash per share (mrq)0.21
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.05
Book value per share (mrq)-0.69

Cash flow statement

Operating cash flow (ttm)-27.26M
Levered free cash flow (ttm)-19.97M